CLINICAL_TRIALS
withdrawal
· 2016-10-07
Clinical Trial Update: Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network [Phase 2, Phase 3]
Summary
A clinical trial evaluating integration of iSBIRT for teen substance use into a pediatric network has been withdrawn after Phase 2/3 planning.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Children's Hospital | Conditions: Substance Use | Phase 2, Phase 3 | Status: WITHDRAWN